- Open Access
COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria
Bulletin of the National Research Centre volume 47, Article number: 45 (2023)
Since the outbreak of coronavirus (COVID-19) disease was reported in 2019, huge human and material resources have been expended globally to combat the spread of the disease. Achieving herd immunity through mass vaccination remains an important strategy to adopt in the war against this disease since it is practically impossible for 60–70% of the population to achieve immunity through natural infection alone. Unfortunately, there have been widespread reports of COVID-19 vaccine hesitancy. This study aims to systematically review the literature to provide an up-to-date assessment of COVID-19 vaccine acceptance rates and also explore factors impacting COVID-19 vaccine hesitancy among adults in Nigeria.
Main body of the abstract
A systematic search of indexed electronic peer-reviewed literature published from 2019 onwards was conducted in Science Direct, PubMed, ProQuest, and EBSCOhost databases and reported according to the PRISMA checklist and Synthesis without meta-analysis (SWiM) in systematic review reporting guidelines. Fifteen out of the 148 studies retrieved, met the inclusion criteria and these were critically appraised using the Centre for Evidence-Based Medicine Critical Appraisal checklist and Mixed Methods Appraisal Tool, version 2018. Basic descriptive statistic (percentage) was employed in the analysis of acceptance rates of the COVID-19 vaccine among various subgroups of adults in Nigeria, while a thematic analysis of the facilitators and barriers to the uptake of the COVID-19 vaccine in Nigeria was conducted. Acceptance rates ranging from 24.3% to 49.5% were observed across the four studies conducted among the high-risk populations in Nigeria, while the acceptance rates among the low-risk populations ranged from 26.0% to 86.2%. Themes such as socio-demographic factors, perception of risk factors, and concerns about the vaccine's safety and efficacy act interchangeably as facilitators and barriers to the uptake of COVID-19 vaccines, whereas political factors, conspiracy theories, and cost primarily act as barriers to vaccine uptake.
Substantial heterogeneity was observed in COVID-19 vaccine acceptance rates among adults in Nigeria. More than half of the studies reviewed reported acceptance rates below 60.0%. A multidisciplinary approach is recommended in engaging important stakeholders, to effectively address COVID-19 vaccine hesitancy in Nigeria.
A novel communicable disease, the COVID-19 infection, was first reported in Wuhan, Hubei province in China on November 17, 2019 (Bryner 2020). After a rapid spread to every continent of the world, the World Health Organization (WHO) classified the outbreak as a pandemic in March 2020. COVID-19 is a communicable respiratory disease caused by a virus belonging to the coronavirus family and known as the severe acute respiratory syndrome coronavirus 2 (SARSCoV2). As of mid-January 2022, a total of 335 million cases of COVID-19 infections had been recorded worldwide and 5.5 million deaths occurred as a result of this deadly disease (Worldometer 2022). Furthermore, over 10,000 frontline healthcare workers were infected across Africa (WHO 2021).
Although vaccines generally require years of research and testing before they can be used in clinical settings, the COVID-19 pandemic led scientists into a race to generate safe and effective coronavirus vaccinations in record time in 2020. As of June 13, 2022, about 122 COVID-19 vaccines were already undergoing human clinical trials, and 49 were nearing completion while 12 vaccines had been approved for human use (Corum et al. 2022). Despite the approval of some of these COVID-19 vaccines, for the prevention of the COVID-19 disease, (BNT162b vaccine produced by Pfizer, ChAdOx1 nCoV-19 vaccine produced by Oxford–AstraZeneca, Moderna, Sputnik V, and Johnson & Johnson) the uptake of these vaccines has been suboptimal worldwide (Sallam et al. 2021).
The term "vaccine hesitancy" refers to the reluctance of some individuals within the population to receive safe and recommended available vaccines. With regards to its scope, vaccine hesitancy can be conceptualised as existing on a continuum that extends from individuals who accept all vaccines without any reservations to individuals who refuse all vaccines without any reservations, with individuals who are vaccine-hesitant making up the diverse groups that exist between these two extremes (MacDonald 2015). Vaccine hesitancy has been widely researched and documented as a phenomenon (Dubé et al. 2018). This concept existed before the COVID-19 crisis and over the years has negatively impacted the efforts being made to control and eradicate some infectious diseases such as poliomyelitis (Machingaidze and Wiysonge 2021). In addition, vaccine hesitancy has been designated as one of the top ten obstacles to attaining global health by the WHO, a phenomenon capable of reversing the advancements made in combating vaccine-preventable diseases (WHO 2019).
COVID-19 vaccine hesitancy has been documented by researchers in high, middle, and low-income countries all over the world (Dhama et al. 2021; Sallam 2021; Aw et al. 2021). This situation is not specific to any country, community, or religion. As early as the summer of 2020, researchers and professionals in the field of public health voiced their concerns regarding the existence of COVID-19 vaccine hesitancy in the United States of America (Khubchandani et al. 2021). Anti-vaccine campaigners were spreading rumours that coronavirus vaccinations were being used to implant microchips. A now-deleted YouTube video made in 2020 pushing pandemic conspiracy theories and claiming immunisation would "kill millions" had over 8 million views (Ball 2020).
COVID-19 vaccine hesitancy in Nigeria
Nigeria was the first country in Sub-Saharan Africa to announce a confirmed case of COVID-19 infection, and this index case was reported on February 27, 2020 (Siwatu et al. 2020). As of May 27, 2022, Nigeria had recorded a total of 256,028 confirmed cases of COVID-19 across all states and 3,143 deaths (NCDC 2021). The pandemic disproportionately affected males with a male/female ratio of 60:40 cases and 74:26 deaths. Individuals over the age of 50 accounted for 70% of the mortality burden. All thirty-six states are affected, but Lagos and the Federal Capital Territory reported the most cases (NCDC 2021). However, it's possible that these numbers don't accurately reflect the severity of COVID-19 disease in Nigeria because the country had only tested 5,160,280 people at the time of this report, despite a population of around 200 million (NCDC 2021). Also, in the year 2020, some people died in Kano State, and the cause of these deaths remain unknown (Akinwotu and Burke 2020).
In compliance with the global trend, the Nigerian government instituted public health measures by prohibiting public gatherings and restricting movement and businesses to combat the infection. However, compliance with these public health measures was a great challenge in a country such as Nigeria where the relationship between the government and the populace is marred by a lack of trust. Other factors such as poverty, overcrowding and lack of potable water also made compliance with these public health measures difficult in many sub-Saharan African countries including Nigeria (Solomon et al. 2022).
Although the incidence of COVID-19 infection has been on a downward trend suggesting a decrease in cases, the second wave experienced by the country in December 2020, and non-adherence to non-pharmaceutical preventive measures underscores the need for a vaccine. It is important to note that throughout its history, Nigeria has struggled with vaccine hesitancy and refusal, which over the years resulted in the loss of public confidence in vaccination programmes. For instance, the polio vaccine boycott in Northern Nigeria in 2003 was sparked by rumours that the polio vaccine contained anti-fertility chemicals and HIV (Yahya 2007). Following the vaccine boycott, wild polio re-infection was experienced in 20 African and Asian countries. The Nigerian government engaged numerous stakeholders, such as religious leaders, traditional rulers, non-governmental organisations, vaccine programme officers, and World Health Organisation representatives, in order to restore public trust and end the oral polio vaccine boycott.
At first, the inadequate supply of COVID-19 vaccine in Nigeria was the primary reason for the country's low vaccination rate, since the vaccines were manufactured outside of Nigeria. However, with an increase in supply, the supply-and-demand dynamic took effect, and vaccine acceptance became a crucial factor in determining coverage. Low COVID-19 uptake has significant negative consequences, which cannot be overemphasised. For instance, achieving herd immunity to disrupt the spread of this infection is nearly impossible without a high vaccination rate. For herd immunity to be achieved based on current estimates, more than 60% of the population would need to have either a natural COVID-19 infection or vaccination (Altmann et al. 2020).
Nigeria and the majority of African nations did not meet the December 2021 vaccination target of 40 per cent. According to the data obtained from the National Primary Health Care Development Agency (NPHCDA), the number of fully vaccinated individuals was 9.8 per cent (10,925,624) as of March 19, 2022, and health experts are concerned that the country will not meet the 70 per cent target by June 2022 if drastic action is not taken (Obinna 2022). Similarly, global data indicated that only 13% of the Nigerian population had been fully vaccinated as of June 18, 2022 as depicted in Fig. 1 below (Ritchie et al. 2022).
Furthermore, studies conducted in Northern Nigeria reported that acceptance of the COVID-19 vaccine was less than optimal among adults in the metropolitan area of Kano (Iliyasu et al. 2021a). Also, a cross-sectional survey conducted at a Nigerian university in the eastern part of Nigeria reported a COVID-19 vaccine hesitancy rate of 65.04% (Uzochukwu et al. 2021). This high hesitancy rate is disconcerting for a tertiary institution and warrants exploration into the root causes of COVID-19 vaccine hesitancy in Nigeria.
It is imperative to end the pandemic because it has significant negative impacts on the economy, mental health, education, and social activities globally. The International Monetary Fund predicts an output loss of close to $9 trillion for the global economy due to this pandemic over the next 2 years (IMF 2020). Therefore, it is critical to understand the various reasons why Nigerians accept or reject the COVID-19 vaccine and the dynamics of COVID-19 vaccine hesitancy in Nigeria. This will allow the government and other policymakers to tailor health promotion interventions to address the specific causes of COVID-19 vaccine hesitancy among the Nigerian population.
This study therefore aims to systematically review the literature to explore factors impacting COVID-19 vaccine hesitancy among adults in Nigeria while the objectives of the study are as follow (i) To compare acceptance rates of the COVID-19 vaccine among high- and low-risk adults in Nigeria (ii) To explore the perceptions of adults in Nigeria regarding facilitators and barriers to COVID-19 vaccine acceptance.
This systematic review was guided by the Synthesis without meta-analysis (SWiM) in systematic review reporting guidelines and the PRISMA checklist (Moher et al. 2016). The research protocol was registered on PROSPERO (Prospero registration number: CRD42022314382) after an initial search on Google scholar and PROSPERO showed that no systematic review on the facilitators and barriers to the uptake of COVID-19 vaccine among various subgroups of adults in Nigeria had been conducted.
A systematic search of indexed peer-reviewed literature published from 2019 onwards was conducted in the following electronic databases: Science Direct, PubMed, ProQuest, and EBSCOhost (Medline and Cinahl). To ensure retrieval of relevant articles, database searches were carried out using keywords, phrase searching and controlled vocabulary searching through database-specific indexing terms. Boolean operators, truncation and field tags were also incorporated. The search terms containing relevant keywords were combined as follows “COVID-19 Vaccines" OR "Coronavirus Vaccin*" OR "SARS COV 2 Immunisation" OR "Covid 19 Vaccin*" AND Hesitancy OR Decline OR Refusal AND Acceptance OR Uptake AND Nigeria OR Nigerian OR Nigerians.
Screening and eligibility
Only studies that met the following inclusion criteria were included: (1) Research publications focusing on all adult populations (> 18 years) eligible for COVID-19 vaccination in Nigeria for instance high-risk populations e.g. healthcare workers, adults with underlying comorbidities or underlying illnesses and low-risk populations e.g. students in tertiary institutions, other adults who are not frontline workers (2) Observational (quantitative, qualitative and mixed-method) studies evaluating or reporting primary and secondary data on factors impacting COVID-19 vaccine uptake in Nigeria (3) Studies published from 2019 onward (4) Studies published in peer-reviewed journals in the English language. According to the American Centre for Disease Control, high-risk individuals are those with an increased risk of developing severe illness if infected with the COVID-19 virus and these include frontline healthcare workers, individuals with underlying chronic medical conditions such as hypertension, diabetes, chronic renal failure, bronchial asthma, cancer, and immunosuppressive states e.g. HIV/AIDS (CDC 2022). Excluded articles include: (1) Studies evaluating barriers to the uptake of other vaccines in Nigeria e.g. HPV or POLIO vaccines (2) Studies evaluating barriers to the uptake of other COVID-19 prevention methods e.g. Physical distancing, isolation and face masks (3) Literature reviews (4) Editorials and opinion pieces and (5) Book chapters.
Rayyan, an online reference management software, was utilised to organise peer-reviewed articles and manage the screening process. After duplicates were removed, the remaining articles were screened in phases to decrease the number of texts. The first stage involved title and abstract screening. Two reviewers (TB and VI) independently performed the screening, while a third reviewer (DM) resolved conflicts. This was followed by the second stage of double independent screening in which full-text screening of articles was conducted.
The eligible articles were critically appraised for methodological quality using the Centre for Evidence-Based Medicine Critical Appraisal checklist for cross-sectional studies, while the Mixed Methods Appraisal Tool (MMAT), version 2018 was used for the critical appraisal of quantitative descriptive and mixed method studies. Studies were classified into good, fair, and poor quality based on the level of compliance with the criteria in the assessment tools.
Data extraction and analysis
Data extraction from the included peer-reviewed studies was conducted using Microsoft Excel. Demographic information and key data extracted from each study include citation (the author's name and the year of the study), country of study, the aim of the study, study population characteristics, study setting, study design, sample size, sampling technique, sample analysis method and data source. The level of acceptability of COVID-19 vaccines among high-risk and low-risk adults in Nigeria was analysed, summarised and compared using basic descriptive statistics (percentages), while a thematic analysis of the facilitators and barriers to the uptake of COVID-19 vaccine was conducted using the inductive coding approach.
This systematic review is an evaluation of published, publicly accessible studies and did not require the collection of original data or any interaction with human subjects. Ethical approval was obtained from the University of Essex Online, United Kingdom.
A total of 161 records identified from the four databases were exported into Rayyan systematic review software and duplicates were removed, leaving 148 records to be screened (Fig. 2). The kappa test of inter-rater agreement between reviewers was 0.83. Full-text screening was conducted to further assess the remaining 23 articles for eligibility before data extraction. Eight articles were excluded mainly due to being the wrong publication type (n = 4) or having the wrong outcome (n = 4). At the end of the process, 15 articles were eligible for inclusion in the review with an inter-rater agreement of κ = 0.95.
The main characteristics of studies included in the review are summarised in Table 1. Tools used by researchers to assess COVID-19 vaccine acceptance and hesitancy were pretested self-administered paper-based and online questionnaires (Google forms). For the qualitative part of the mixed-method studies, in-depth interviews were conducted by researchers with the recordings transcribed word-for-word, and a thematic analysis was conducted using the "Framework Approach”.
Acceptance rates of COVID-19 vaccines among high-risk populations in Nigeria
Four out of the 15 articles included in this systematic review assessed the acceptance rates of the COVID-19 vaccine among high-risk populations.
A range of acceptance rates from 24.3 to 49.5% was observed across the four studies conducted among the high-risk populations in Nigeria (Fig. 3). In addition, the study conducted by Agha et al. (2021) showed that only 33.0% of the respondents had taken two doses of the COVID-19 vaccine as of July 2021.
Acceptance rates of COVID-19 vaccine among low-risk populations in Nigeria
Online and telephone surveys on willingness to accept the COVID-19 vaccine in African countries, including Nigeria, reported acceptability rates ranging from 26.0% to 86.2% (Fig. 4) (Solís Arce et al. 2021; Anjorin et al. 2021; Harapan et al. 2022). Furthermore, acceptability rates of 66.2%, 51.1%, 34.7%, 43.3% and 74.5%, respectively, were reported among adult populations in various Nigerian states. In addition, only 26.0% of the adult populations surveyed in the Federal Capital Territory (FCT) were willing to accept and pay for the COVID-19 vaccine (Adigwe 2021).
Facilitators of COVID-19 vaccine uptake among adults in Nigeria
The analysis of data using the inductive coding approach produced six themes (categories) with regard to the facilitators and barriers to the uptake of the COVID-19 vaccine among adults in Nigeria.
Key factors responsible for the acceptability of the COVID-19 vaccine include socio-demographic factors, perception of risk factors, and concerns about the safety and efficacy of the vaccine. As shown in Table 2, older age group, high socioeconomic status, higher level of education, male gender, and living in urban areas are the socio-demographic factors that act as facilitators of COVID-19 vaccine uptake in the majority of the studies examined (Iliyasu et al. 2021a; Agha et al. 2021; Adigwe 2021; Adedeji-Adenola et al. 2022; Amuzie et al. 2021; Eze et al. 2021). However, discrepancies were observed in two web-based studies conducted among social media users in Nigeria to assess the acceptability and willingness to pay for hypothetical COVID-19 vaccines (Adebisi et al.2021; Okafor et al. 2021). In these studies, younger adults were statistically significantly associated with high COVID-19 uptake.
In addition, the cross-country comparable, descriptive high-frequency phone study showed a statistically significant association between low-income earners and low levels of education and COVID-19 vaccine uptake (Kayanda et al. 2021). This contradicts the overall picture with regard to socio-demographic predictors of the acceptability of the COVID-19 vaccine. However, the author noted in the limitation section of the study that the population-level representativeness of the results reported may be constrained since the phone survey respondents in the data were not explicitly chosen to be representative of all individuals (Kayanda et al. 2021).
A mixed picture emerged concerning the association between COVID-19 vaccine uptake and socio-demographic factors like religion and marital status (Uzochukwu et al. 2021; Harapan et al. 2022; Amuzie et al. 2021; Eze et al. 2021).
Another major theme identified as a determinant of COVID-19 vaccine uptake among adults in Nigeria is risk perception. Adults who perceived themselves as having higher risks of contracting COVID-19 infection had a significant association with vaccine acceptability (Iliyasu et al. 2021b). These groups include clinical staff/healthcare providers such as doctors, pharmacists, and nurses (Iliyasu et al. 2021b). Other high-risk groups consist of individuals with underlying health problems and chronic medical conditions such as hypertension, diabetes, and HIV/AIDs (Iliyasu et al. 2022). Lastly, concern about safety and efficacy was also identified as a critical factor influencing COVID-19 vaccination uptake among adults in Nigeria. For instance, high vaccine uptake was observed among those who were unperturbed about claims that COVID-19 vaccines are unsafe and can cause infertility (Iliyasu et al. 2021a).
Barriers to the uptake of COVID-19 vaccine among adults in Nigeria
The major themes identified as barriers to the uptake of the COVID-19 vaccine among adults in Nigeria include socio-demographic factors, perception of risk, concern about vaccine safety and efficacy, political factors, conspiracy theory and the cost (Table 3).
Socio-demographic factors such as low socioeconomic status, younger age group, female gender and living in rural areas are statistically significantly associated with COVID-19 vaccine hesitancy among adults in Nigeria (Iliyasu et al. 2021a; Anjorin et al. 2021; Harapan et al. 2022; Adedeji-Adenola et al. 2022; Amuzie et al. 2021; Eze et al. 2021). Conversely, surveys that were carried out online on various social media platforms in order to determine whether or not adults in Nigeria would accept a hypothetical COVID-19 vaccine produced a divergent result in terms of the socio-demographic factors that are responsible for vaccine hesitancy. The outcome of these surveys showed that the older age groups were more vaccine-hesitant (Adebisi et al. 2021; Okafor et al. 2021). Studies, however, have shown that response/social bias is possible in self-administered social media-based studies. Furthermore, because social media users are primarily young adults, older adults, people from lower socioeconomic levels, specific geographical locations, people with lower educational attainment (illiterates), and people without internet access, may inadvertently be excluded from the study (Adebisi et al. 2021). Other socio-demographic factors like religion and marital status did not show a consistent association with vaccine hesitancy.
Perception of risk also plays a critical role in COVID-19 vaccine hesitancy in Nigerian adults. Study participants working in non-healthcare-related jobs, non-clinical hospital staff and individuals without comorbidities were statistically significantly associated with vaccine hesitancy (Agha et al. 2021; Harapan et al. 2022; Adedeji-Adenola et al. 2022; Amuzie et al. 2021; Iliyasu et al. 2021b).
Concern about vaccine safety and efficacy as a theme also emerged as a major barrier to the uptake of the COVID-19 vaccine. Individuals who believe clinical trials are unreliable, those concerned about side effects and vaccine safety due to rapid vaccine development have all demonstrated vaccine hesitancy (Solís Arce et al. 2021; Anjorin et al. 2021; Harapan et al. 2022; Adigwe 2021; Adedeji-Adenola et al. 2022; Kayanda et al. 2021; Iliyasu et al. 2021b).
Conspiracy theories surrounding the COVID-19 pandemic such as misinformation that the pandemic is related to the introduction of 5G technology and the possibility of COVID-19 vaccines causing infertility also significantly associated with vaccine hesitancy among adults in Nigeria (Iliyasu et al. 2021a; Okafor et al. 2021). In addition, requesting payment for the COVID-19 vaccine from the public has also been linked to lower vaccination rates (Adigwe 2021).
As already established, vaccine hesitancy predates the COVID-19 pandemic and poses a threat to world health because it is implicated in the resurgence of vaccine-preventable diseases such as measles and poliomyelitis. Similarly, the global attempt to contain the present epidemic with its detrimental health and socioeconomic repercussions may be limited by COVID-19 vaccine hesitancy (Sallam et al. 2021). Current estimates based on global data indicate that only 13.0% of Nigerians have received a full dosage of COVID-19 vaccinations, and this is significantly less than the 60.0–75.0% required to acquire herd immunity in any community (Ritchie et al. 2022). It is therefore critical to identify the factors responsible for COVID-19 vaccine hesitancy among various subgroups of the Nigerian population to aid policymakers in the establishment of effective interventions to address these issues.
This study shows huge variability in COVID-19 vaccine acceptance rates among various subgroups of the Nigerian population (24.3%–86.2%). This is consistent with other studies conducted on COVID-19 vaccine acceptance in different parts of the world. For instance, substantial heterogeneity was reported in the acceptance rates of the COVID-19 vaccine across the globe with acceptance rates ranging from 23.6% to 97.0% (Sallam et al. 2021). Despite the variability of acceptance rates observed in this study, certain patterns, however, can be deduced from the descriptive analysis of the reported vaccine acceptance rates.
The acceptance rates of the COVID-19 vaccine among high-risk populations range from 24.3 to 49.5%. These rates are not as high as expected considering the fact that such individuals are aware of the possibility of having severe forms of COVID-19 infection due to the presence of underlying health issues and higher levels of exposure.
However, the outcome is consistent with findings from previous studies conducted among healthcare providers around the world. For instance, an acceptance rate of 40.0% was reported among nurses in Hong Kong, while an acceptance rate of 36.0% was noted among healthcare workers in New Mexico (Wang et al. 2020; Shekhar et al. 2021). On the other hand, the acceptance rates observed among low-risk adults in Nigeria range from 26.0 to 86.2%. These results corroborate findings from previous studies conducted in other parts of the world. For instance, acceptance rates of 65.0% and 69.0% were reported among adults in Ireland and the United Kingdom, respectively, while the outcome of a similar study among working adults in France revealed a vaccine acceptance rate of 71.2% (Murphy et al. 2021; Schwarzinger et al. 2021).
Findings from this study show that acceptance rates of the COVID-19 vaccine among the low-risk adult population were higher compared to the high-risk subgroup in Nigeria. This is similar to studies conducted in the USA where an acceptance rate of 36.0% was reported among healthcare providers while a higher acceptance rate of 67.0% was recorded in a general population survey conducted in the USA (Malik et al. 2020). It is therefore imperative to evaluate factors that are predictive of vaccine acceptance among high-risk populations, such as healthcare workers, as this will assist organisations and policy-makers in allocating resources in a manner that will optimise vaccine uptake in the subgroup.
Limited access to scientific information about COVID-19 vaccine research and the approval process have been identified as factors contributing to COVID-19 vaccine hesitancy, particularly among high-risk groups such as healthcare providers (Garrett 2020). In a study of US healthcare workers, 56.0% preferred to wait and evaluate more data on the COVID-19 vaccine before accepting it. This is not surprising given that healthcare workers prefer to base their decisions on published scientific literature rather than anecdotal evidence (Shekhar et al. 2021). Also, the acceptability of COVID-19 vaccine among healthcare workers in Nigeria was assessed using the Fogg Behaviour Model in July 2021, after the arrival of the vaccine, and it was reported that only 33.0% of the study participants had taken two doses of the vaccine (Agha et al. 2021). The study further clarified the reasons for the unexpected low vaccine uptake among high-risk populations like healthcare workers, as it was observed that low motivation and low ability were powerful predictors of COVID-19 vaccine hesitancy. In addition, though high acceptability was reported in most surveys conducted among the low-risk subgroup of the adult populations in Nigeria, some of these surveys assessed the willingness to accept a hypothetical COVID-19 vaccine. Some researchers, however, argued that willingness to accept a vaccine does not always translate to vaccine uptake eventually (Adebisi et al. 2021).
In terms of factors responsible for the uptake of the COVID-19 vaccine, studies conducted in the USA showed that vaccine acceptance increased with increasing age, education, male gender, and income level (Shekhar et al. 2021; Malik et al. 2020). The outcome of this review is consistent with such a claim because the older age group, male gender, higher level of education, and high socioeconomic status were repeatedly mentioned in the reviewed studies as predictors of acceptability of the COVID-19 vaccine (Iliyasu et al. 2021a; Uzochukwu et al. 2021; IMF 2020; Agha et al. 2021; Eze et al. 2021).
Other factors acting as facilitators of COVID-19 vaccine uptake in this study include high-risk perception; for instance, individuals who are frontline healthcare providers and those with chronic medical conditions were found to be less vaccine-hesitant in some studies. Also, receiving flu vaccination in the past few months, which indicates a belief in the efficacy and benefits of vaccination, was found to be statistically significantly associated with COVID-19 vaccine uptake (Anjorin et al. 2021; Harapan et al 2022). These results are consistent with studies conducted in Northern Italy where past vaccination refusal and absence of comorbidities were reported as important predictors of COVID-19 vaccine refusal (Reno et al. 2021).
The barriers revealed in this study include socio-demographic factors, perception of risk, concern about vaccine safety and efficacy, political factors, conspiracy theories, and cost. This review, therefore, has demonstrated that COVID-19 vaccine hesitancy in Nigeria is due to a complex interplay of many factors at different levels. Socio-demographic variables such as younger age group, low socio-economic status, female gender, and lower level of education were revealed as barriers to the uptake of the COVID-19 vaccine. Also, individuals who perceive themselves as having a low risk of contracting COVID-19 infection were found to be vaccine-hesitant in this study. This corroborates other studies conducted in other parts of the world. For instance, it was discovered that outright vaccine refusal and vaccine reluctance among working adults in France were both substantially associated with female gender, age, lower educational level, poor compliance with recommended immunisations in the past, and no report of defined chronic diseases (Schwarzinger et al. 2021). Invincibility, low-risk perception, and the rebellious character of young adults are all possible explanations for vaccine hesitancy among young adults in Nigeria (Iliyasu et al. 2021a).
With regard to concerns about vaccine safety, studies have shown that beliefs that vaccinations aren't safe or effective, as well as growing anxiety over the quick development of COVID-19 vaccines, are all contributing to vaccine hesitancy (Aw et al. 2021). Similarly, the findings of this study established vaccine safety and efficacy concerns as a substantial barrier to COVID-19 vaccine uptake. People's perceptions of COVID-19 vaccines in Nigeria include the ideas that they are unsafe and that clinical trials are not trustworthy (Solís Arce et al. 2021; Adigwe 2021; Adebisi et al. 2021; Kayanda et al. 2021; Iliyasu et al. 2021b).
Furthermore, this review also established that COVID-19 vaccine hesitancy is strongly associated with a negative relationship between the government and the citizens. Distrust in the government and dissatisfaction with the COVID-19 crisis management policies of the government are important predictors of COVID-19 vaccine hesitancy (Iliyasu et al. 2021a). This result corroborates other studies’ findings on determinants of COVID-19 vaccine hesitancy. For instance, in a study conducted among eligible Japanese adults, mistrust towards the government was mentioned as one of the reasons for the refusal of the COVID-19 vaccine (Okubo et al. 2021). Similarly, studies have shown that having a positive view of public sector officials and the UK government led to a significant increase in willingness to get vaccinated (Chaudhuri et al. 2022). In addition, it was discovered that people in Australia were more likely to plan to get vaccinated if they had more confidence in their state or territory government or hospitals (Edwards et al.2021).
The outcome of various studies conducted all over the world showed that the existence of a great number of conspiracy theories and false narratives may act as substantial hurdles to the uptake of COVID-19 vaccinations. The findings of this study support this assertion, as the inhibitory effects of conspiracy theories on vaccine uptake have been observed in some of the studies reviewed (Iliyasu et al. 2021a). Finally, cost is a critical determinant of COVID-19 vaccine hesitancy among Nigerian adults because only 26% of respondents were willing to pay to receive the COVID-19 vaccine among respondents (Adigwe 2021).
In a rapid review study of the COVID-19 vaccine acceptance rate and the associated factors in Nigeria conducted in December 2021, it was reported that propaganda, conspiracy theories, and worries about harmful effects were the root causes of COVID-19 vaccine hesitancy (Olu-Abiodun et al. 2022). This systematic review has, however, provided fresh insights on anti-COVID-19 vaccination behaviour in various subgroups of adults in Nigeria and the mechanisms that underpin it, by uncovering additional factors such as cost, perception of risk, political and socio-demographic factors as major barriers to the uptake of the vaccine in Nigeria. On the whole, there is a need for policies to address these issues for the Nigerian government to be able to achieve its goal of vaccinating 70% of 200 million people by 2022 (Usigbe 2021).
Nigeria got 3.92 million doses of COVID-19 vaccination through the COVAX facility on March 2, 2021. The arrival represented a significant milestone toward assuring equitable global distribution of COVID-19 vaccinations in the largest vaccine procurement and supply operation in history (WHO 2021). However, due to limited supply, the vaccine was rolled out in stages to different subgroups of the population, with healthcare workers being one of the first subgroups to receive it in Nigeria, as was the case in the United States. For the first phase of the COVID-19 vaccine roll-out, which mainly targeted frontline workers, 98.9% (3,980,600 doses) of the first tranche of Astra Zeneca vaccines were used in the first phase, with over 2.5 million people having received the 1st dose of the vaccines, of which over 1.4 million people have received the 2nd dose, reaching 2.3% of the eligible population (WHO 2021).
By the time the second phase of COVID-19 vaccination was launched in August 2021, the reasons for poor vaccine coverage had shifted from inadequate vaccine supply to low turnout and suboptimal COVID-19 vaccine uptake caused by the factors enumerated above.
Strengths and limitations
One of the main strengths of this study is the screening procedure adopted for the included citations. Each citation was screened by two reviewers, and disagreements were resolved by a senior author. The same was done for quality assessment to ensure robust evidence. This study also demonstrated the usefulness of systematic reviews in revealing knowledge gaps associated with a given issue.
On the other hand, the following are some of the study's limitations. Some of the studies reviewed used survey data, which is susceptible to selection, response, and recall biases. During the pandemic, many researchers resorted to conducting COVID-19 disease-related studies online because leveraging the internet for studies during the outbreak minimised contact and the associated COVID-19 infection risk while generating valuable insights from these studies. So, many of the surveys conducted among low-risk populations were either internet, telephone, or social media-based studies. However, conducting studies online may inadvertently result in the selection of a more urban, young-to-middle-aged, and highly educated population while excluding older adults, people from lower socioeconomic levels, particular geographical places, lower educational attainment, and people without internet access (Adebisi et al. 2021). This may subsequently limit the generalisability of the studies reviewed since the online participants may not truly represent the population in a country like Nigeria. Also, measurement errors may occur in studies conducted with population-based data, leading to information bias.
Substantial variability in COVID-19 vaccine acceptance rates was observed among different subgroups of adults in the Nigerian population. More than half of the studies reviewed reported acceptance rates below 60.0%, and this could negatively impact efforts to control the current COVID-19 pandemic. Factors impacting the acceptance and refusal of the COVID-19 vaccine in Nigeria include socio-demographic factors; perception of risk; concern about vaccine safety and efficacy; political factors; conspiracy theory; and cost.
Furthermore, high motivation and ability have been identified as important predictors of COVID-19 vaccine uptake among healthcare workers (Agha et al. 2021). It is therefore imperative to further research into factors responsible for low motivation and low ability among healthcare workers and mitigate them to improve COVID-19 vaccine uptake among the subgroup. It is crucial to increase vaccination rates among healthcare workers and provide them with evidence-based information regarding the COVID-19 vaccine for the following reasons. Firstly, increased COVID-19 vaccine uptake is essential to curtail the spread of the infection among healthcare providers and prevent the loss of critical manpower needed to combat the pandemic. In addition, healthcare providers are a primary source of health education and literacy in the community; thus, they must be better prepared to counter arguments against COVID-19 vaccination uptake and challenge mistrust at all levels of the community.
In general, government agencies, policymakers, public health institutions, non-governmental organizations (NGOs), advocacy groups, mainstream media, and social media operators must collaborate to overcome the challenge of COVID-19 vaccine hesitancy. Because they influence the public, the Nigerian government should also work towards gaining the trust of key stakeholders and opinion leaders such as market heads, religious leaders, celebrities, traditional and cultural leaders so they can assist government agencies in tackling COVID-19 vaccine hesitancy by effectively engaging members of the community.
When health promotion activities are supported by health promotion theories such as the diffusion of innovations model, nudge theory, trans-theory model, and health belief model, they are more successful (Eldredge et al. 2016). Relevant government agencies should therefore create targeted community-based interventions based on these theories.
Disseminating scientific and evidence-based information on how safe and effective licensed COVID-19 vaccines are through digital as well as traditional media such as radio, television, and print would also help ensure that accurate information reaches remote regions of the country because everyone needs evidence-based information. This will boost the confidence of Nigerian citizens in the COVID-19 vaccine and increase their willingness to accept it (Olu-Abiodun et al. 2022).
Availability of data and materials
Data supporting this systematic review are available in the reference section. In addition, the datasets used or analysed during the current study are available from the corresponding author on reasonable request.
Centre for disease control
Coronavirus disease 2019
COVID-19 vaccines global access
Human immunodeficiency virus
Human papilloma virus
International monetary fund
Nigerian centre for disease control
Preferred reporting items for systematic reviews and meta-analyses
Synthesis without meta-analysis
United States of America
World health organisation
Adebisi YA, Alaran AJ, Bolarinwa OA, Akande-Sholabi W, Lucero-Prisno DE (2021) when it is available, will we take it? Social media users’ perception of hypothetical COVID-19 vaccine in Nigeria. Pan Afri Med J 38
Adedeji-Adenola H, Olugbake OA, Adeosun SA (2022) Factors influencing COVID-19 vaccine uptake among adults in Nigeria. PLoS ONE 17(2):e0264371
Adigwe OP (2021) COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria. Vaccine X 9:100112
Agha S, Chine A, Lalika M, Pandey S, Seth A, Wiyeh A, Seng A, Rao N, Badshah A (2021) Drivers of COVID-19 vaccine uptake amongst healthcare workers (HCWs) in Nigeria. Vaccines 9(10):1162
Akinwotu E, Burke J (2020) Deaths in Nigerian city raise concerns over Undetected Covid-19 outbreaks | World news | The Guardian. Available from https://www.theguardian.com/world/2020/apr/28/nigerian-authorities-deny-waveof-deaths-is-due-to-covid-19 [Accessed 25 May 2022]
Altmann DM, Douek DC, Boyton RJ (2020) What policy makers need to know about COVID-19 protective immunity? Lancet 395(10236):1527–1529
Amuzie CI, Odini F, Kalu KU, Izuka M, Nwamoh U, Emma-Ukaegbu U, Onyike G (2021) COVID-19 vaccine hesitancy among healthcare workers and its sociodemographic determinants in Abia State, Southeastern Nigeria: a cross-sectional study. Pan Afr Med J 40
Anjorin AA, Odetokun IA, Abioye AI, Elnadi H, Umoren MV, Damaris BF, Eyedo J, Umar HI, Nyandwi JB, Abdalla MM, Tijani SO (2021) Will Africans take COVID-19 vaccination? PLoS ONE 16(12):e0260575
Aw J, Seng JJB, Seah SSY, Low LL (2021) COVID-19 vaccine hesitancy—A scoping review of literature in high-income countries. Vaccines 9(8):900
Ball P (2020) Anti-vaccine movement could undermine efforts to end Coronavirus pandemic, researchers warn. Nature 581(7808):251–252
Bryner J (2020) Live Science: 1st known case of Coronavirus traced back to November 2019 in China Available from: https://www.livescience.com/first-case-coronavirus-found.html [Accessed 31 May 2022]
Centres for Disease Control and Prevention (2022) Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/index.html [Accessed 03 July 2022]
Chaudhuri K, Chakrabarti A, Chandan JS, Bandyopadhyay S (2022) COVID-19 vaccine hesitancy in the UK: a longitudinal household cross-sectional study. BMC Public Health 22(1):1–13
Corum J, Grady D, Wee SL, Zimmer C (2022) Coronavirus vaccine tracker. The New York Times [Accessed 19 June 2022]
Dhama K, Sharun K, Tiwari R, Dhawan M, Emran TB, Rabaan AA, Alhumaid S (2021) COVID-19 vaccine hesitancy–reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum Vaccin Immunother 17(10):3495–3499
Dubé E, Gagnon D, MacDonald N, Bocquier A, Peretti-Watel P, Verger P (2018) Underlying factors impacting vaccine hesitancy in high-income countries: a review of qualitative studies. Expert Rev Vaccin 17(11):989–1004
Edwards B, Biddle N, Gray M, Sollis K (2021) COVID-19 vaccine hesitancy and resistance: correlates in a nationally representative longitudinal survey of the Australian population. PLoS ONE 16(3):e0248892
Eldredge LKB, Markham CM, Ruiter RA, Fernández ME, Kok G, Parcel GS (2016) Planning health promotion programs: an intervention mapping approach. John Wiley & Sons [Accessed 20 July 2022]
Eze UA, Ndoh KI, Ibisola BA, Onwuliri CD, Osiyemi A, Ude N, Chime AA, Ogbor EO, Alao AO, Abdullahi A (2021) Determinants for acceptance of COVID-19 vaccine in Nigeria. Cureus 13(11) [Accessed 16 May 2022]
Garrett L (2020) COVID-19: the medium is the message. Lancet 395(10228):942–943
Harapan H, Anwar S, Yufika A, Sharun K, Gachabayov M, Fahriani M, Husnah M, Raad R, Abdalla RY, Adam RY, Khiri NM (2022) Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic. Pathog Global Health, pp1–8 [Accessed 20 April 2022]
Iliyasu Z, Umar AA, Abdullahi HM, Kwaku AA, Amole TG, Tsiga-Ahmed FI, Garba RM, Salihu HM, Aliyu MH (2021a) “They have produced a vaccine, but we doubt if COVID-19 exists”: correlates of COVID-19 vaccine acceptability among adults in Kano, Nigeria. Hum Vaccin Immunother 17(11):4057–4064
Iliyasu Z, Garba MR, Gajida AU, Amole TG, Umar AA, Abdullahi HM, Kwaku AA, Salihu HM, Aliyu MH (2021b) ‘Why should I take the COVID-19 vaccine after recovering from the disease? ‘A mixed-methods study of correlates of COVID-19 vaccine acceptability among health workers in Northern Nigeria. Pathog Global Health 116(4):254–262
Iliyasu Z, Kwaku AA, Umar AA, Tsiga-Ahmed F, Nass NS, Abdullahi HM, Amole TG, Salihu HM, Aliyu MH (2022) Predictors of COVID-19 vaccine acceptability among patients living with HIV in northern Nigeria: a mixed methods study. Curr HIV Res 20(1):82–90
International Monetary Fund Blog (2020) The great lockdown: worst economic downturn since the great depression. https://blogs.imf.org/2020/04/14/thegreat-lockdown-worst-economic-downturn-since-the-great-depression/ (2020) [Accessed 23 May 2022]
Kanyanda S, Markhof Y, Wollburg P, Zezza A (2021) Acceptance of COVID-19 vaccines in sub-Saharan Africa: evidence from six national phone surveys. BMJ Open 11(12):e055159
Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ (2021) COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Commun Health 46(2):270–277
MacDonald NE (2015) Vaccine hesitancy: definition, scope and determinants. Vaccine 33(34):4161–4164
Machingaidze S, Wiysonge CS (2021) Understanding COVID-19 vaccine hesitancy. Nat Med 27(8):1338–1339
Malik AA, McFadden SM, Elharake J, Omer SB (2020) Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine 26:100495
Moher D, Stewart L, Shekelle P (2016) Implementing PRISMA-P: recommendations for prospective authors. Syst Rev 5(1):1–2
Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, McKay R, Bennett K, Mason L, Gibson-Miller J, Levita L (2021) Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun 12(1):1–15
Nigerian Centre for Disease Control COVID-19 Microsite (2021) COVID-19 NIGERIA. Available from: https://covid19.ncdc.gov.ng/state// [Accessed 28, May 2022]
Obinna C (2022) In Nigeria, vaccine hesitancy, non-compliance hindering herd immunity Available from: https://www.vanguardngr.com/2022/03/in-nigeria-vaccine-hesitancy-non-compliance-hindering-herd-immunity-2/ [Accessed 31 May 2022]
Okafor UG, Isah A, Onuh JC, Mgbemena CB, Ubaka CM (2021) Community acceptance and willingness to pay for hypothetical COVID-19 vaccines in a developing country: a web-based nationwide study in Nigeria. Pan Afr Med J [Accessed 15 May 2022]
Okubo R, Yoshioka T, Ohfuji S, Matsuo T, Tabuchi T (2021) COVID-19 vaccine hesitancy and its associated factors in Japan. Vaccines 9(6):662
Olu-Abiodun O, Abiodun O, Okafor N (2022) COVID-19 vaccination in Nigeria: a rapid review of vaccine acceptance rate and the associated factors. PLoS ONE 17(5):e0267691
Reno C, Maietti E, Fantini MP, Savoia E, Manzoli L, Montalti M, Gori D (2021) Enhancing COVID-19 vaccines acceptance: results from a survey on vaccine hesitancy in Northern Italy. Vaccines 9(4):378
Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, Hasell J, Macdonald B, Beltekian D, Roser M (2022) Coronavirus (COVID-19) Vaccinations-Our World in Data. Available from: https://ourworldindata.org/covid-vaccinations [Accessed 19 June 2022]
Sallam M (2021) COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines 9(2):160
Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A (2021) High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines 9(1):42
Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S (2021) COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health 6(4):e210–e221
Shekhar R, Sheikh AB, Upadhyay S, Singh M, Kottewar S, Mir H, Barrett E, Pal S (2021) COVID-19 vaccine acceptance among healthcare workers in the United States. Vaccines 9(2):119
Siwatu GO, Palacios-Lopez A, Mcgee KR, Amankwah A, Contreras Gonzalez IM, Vishwanath T, Lain JW, Jenq C, Azad M (2020) Impact of COVID-19 on Nigerian households: 5th round results. [Accessed 28 May 2022]
Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, Anigo D (2021) COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries. Nat Med 27(8):1385–1394
Solomon H, Thea DM, Galea S, Sabin LL, Lucey DR, Hamer DH (2022) Adherence to and enforcement of non-pharmaceutical interventions (NPIs) for COVID-19 prevention in Nigeria, Rwanda, and Zambia: A mixed-methods analysis. MedRxiv [Accessed 31 May 2022]
Usigbe L (2021) Nigeria: COVID-19 vaccine rollout kicks off in Africa’s most populous country. Available from: https://www.un.org/africarenewal/magazine/april-2021/nigeria-covid-19-vaccine-rollout-kicks-africas-most-populous-country [Accessed 13 July 2022]
Uzochukwu IC, Eleje GU, Nwankwo CH, Chukwuma GO, Uzuke CA, Uzochukwu CE, Mathias BA, Okunna CS, Asomugha LA, Esimone CO (2021) COVID-19 vaccine hesitancy among staff and students in a Nigerian tertiary educational institution. Ther Adv Infect Disease 8:20499361211054924
Wang K, Wong ELY, Ho KF, Cheung AWL, Chan EYY, Yeoh EK, Wong SYS (2020) Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: a cross-sectional survey. Vaccine 38(45):7049–7056
World Health Organisation, Top ten threats to global health (2019) Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global -health-in-2019 [Accessed 20 January 2022]
World health organisation (2021) Nigeria records another milestone launches the second phase of COVID-19 vaccination. Available from: https://www.afrowho.Int/news /Nigeria-records-another-milestone-launches-second-phase-covid-19-vaccination [Accessed 13 July 2022]
Worldometer (2022) Coronavirus Pandemic. Available from: https://www.worldometers.info/coronavirus/ [Accessed 20 January 2022]
Yahya M (2007) Polio vaccines—“no thank you!” barriers to polio eradication in Northern Nigeria. Afr Aff 106(423):185–204
My sincere gratitude goes to the reviewers, for conducting a thorough review of this manuscript.
This research received no external funding.
Ethics approval and consent to participate
Ethical approval was obtained from the University of Essex Online, United Kingdom.
Consent for publication
The authors declare that they have no competing interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Babatope, T., Ilyenkova, V. & Marais, D. COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria. Bull Natl Res Cent 47, 45 (2023). https://doi.org/10.1186/s42269-023-01017-w
- COVID-19 vaccines
- Vaccine hesitancy